FAP-Targeted Molecular Imaging of CAFs-Mediated Chemoresistance and Reversal by JAK/STAT Inhibition in Gastric Cancer

Authors: Wang, Xiaoyu; Wang, Chunting; Yang, Ningxin; Huang, Yuelin; Chen, Yanhong; Yao, Defan; Ren, Gang

Source journal: Cancer letters (2026-11-16)

DOI: 10.1016/j.canlet.2026.218976

Abstract

Chemotherapy resistance remains a major obstacle in the clinical management of gastric cancer (GC), driven largely by cancer-associated fibroblasts (CAFs). CAFs activate the JAK/STAT signaling pathway in GC cells, promoting proliferation, migration, and resistance to 5-fluorouracil (5-FU). Fibroblast activation protein (FAP), highly expressed on CAFs but minimally in normal tissues, is an attractive target for molecular imaging. Here, we developed FAPtp-ICG, a near-infrared fluorescent probe comprising an FAP-targeting peptide conjugated to indocyanine green (ICG), for noninvasive visualization of FAP expression. We established CAFs-conditioned GC models with graded chemoresistance, in which FAP-associated fluorescence and FAP expression were positively associated with the degree of CAFs-mediated 5-FU resistance in the experimental models. FAPtp-ICG enabled noninvasive fluorescence imaging of FAP-associated stromal changes, allowing longitudinal assessment of treatment-associated changes related to CAFs-mediated drug resistance. Mechanistically, combination therapy with 5-FU and ruxolitinib (RUX) suppressed JAK/STAT signaling, alleviated chemoresistance, inhibited tumor growth, and restored drug sensitivity. Multi-omics profiling further revealed that RUX treatment was associated with transcriptomic and proteomic alterations in the tumor microenvironment, attenuating inflammatory signaling, immune cell recruitment, and extracellular matrix remodeling. By integrating a FAP-targeted optical probe with therapeutic JAK/STAT inhibition, this work demonstrates a theranostic strategy for assessing and overcoming CAFs-mediated chemoresistance in GC, supporting the potential utility of FAP-targeted imaging for longitudinal assessment of treatment-associated stromal changes.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.